You are here
Browse Categories
Offerings On Manhattan Street Capital
Genprex (S-1 IPO) expects to list on the NASDAQ on Friday March 16th - two days left. Their Oncoprex medicine delivers DNA to lung cancer cells via custom nanoparticles and causes low side effects. The DNA string adjusts cell signaling to trigger cancer cell death. Genprex is raising $6.5 mill at a...
InSitu Biologics - AnestaGel™ - Eliminate the need for addictive opiates for pain management after surgery.
AnestaGel™ is a non-opioid pain relief drug based on...
ERC Homebuilders 1 - Focused real estate homebuilder in Florida. Anyone can invest
ERC is an early stage homebuilder focused on the fastest growing sector in the US Real...
- ‹‹
- 3 of 3